Grant funds research aimed at ultimately eradicating polio, a highly infectious viral disease. Evaxion will apply its leading AI-Immunology™ platform to identify and combine various antigens to combat the virus and develop design options for a potential new vaccine construct. Risk of a global polio resurgence and health crisis remain, thus a new vaccine concept is warranted.